Cargando…
Factors affecting the therapeutic effect of botulinum toxin A on trigeminal neuralgia: A follow-up retrospective study of 152 patients
Botulinum toxin A (BTX-A) is a promising therapeutic modality against trigeminal neuralgia (TN) with certain controversies pertaining to its application. To provide further information on factors influencing the treatment outcomes of BTX-A, a retrospective study with 152 patients with TN treated wit...
Autores principales: | Zhang, Haifeng, Lian, Yajun, Xie, Nanchang, Cheng, Xuan, Chen, Chen, Xu, Hongliang, Zheng, Yake |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777303/ https://www.ncbi.nlm.nih.gov/pubmed/31602211 http://dx.doi.org/10.3892/etm.2019.7988 |
Ejemplares similares
-
Central antinociceptive activity of peripherally applied botulinum toxin type A in lab rat model of trigeminal neuralgia
por: Wu, Chuanjie, et al.
Publicado: (2016) -
Single-dose botulinum toxin type a compared with repeated-dose for treatment of trigeminal neuralgia: a pilot study
por: Zhang, Haifeng, et al.
Publicado: (2017) -
Botulinum Toxin Type A for refractory trigeminal neuralgia in older patients: a better therapeutic effect
por: Wu, Shouyi, et al.
Publicado: (2019) -
Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial
por: Zhang, Haifeng, et al.
Publicado: (2014) -
Therapeutic Efficacy of Botulinum Toxin in Trigeminal Neuralgia
por: Kayani, Abdul Mueez Alam, et al.
Publicado: (2022)